Cargando…
Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
Epithelial-to-mesenchymal transition (EMT) is associated with tumor metastasis and tumorigenesis in lung cancer stem-like cells (CSCs). However, the exact mechanism underlying this is not clear. We used microarray analysis to identify candidate genes responsible for EMT in spheroid and monolayer cul...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788589/ https://www.ncbi.nlm.nih.gov/pubmed/29416721 http://dx.doi.org/10.18632/oncotarget.11208 |
_version_ | 1783296100930682880 |
---|---|
author | Liu, Chen-Chi Lin, Jiun-Han Hsu, Tien-Wei Hsu, Jyuan-Wei Chang, Jer-Wei Su, Kelly Hsu, Han-Shui Hung, Shih-Chieh |
author_facet | Liu, Chen-Chi Lin, Jiun-Han Hsu, Tien-Wei Hsu, Jyuan-Wei Chang, Jer-Wei Su, Kelly Hsu, Han-Shui Hung, Shih-Chieh |
author_sort | Liu, Chen-Chi |
collection | PubMed |
description | Epithelial-to-mesenchymal transition (EMT) is associated with tumor metastasis and tumorigenesis in lung cancer stem-like cells (CSCs). However, the exact mechanism underlying this is not clear. We used microarray analysis to identify candidate genes responsible for EMT in spheroid and monolayer cultures of lung cancer cells. We found increased expression of a variety of adhesion molecules in CSCs. One of these molecules, Collagen XVII (Col XVII), was demonstrated to be required for maintenance of EMT phenotypes and metastasis ability in lung CSCs. We showed that Col XVII stabilized laminin-5 to activate the FAK/AKT/GSK3β pathway, thereby suppressing Snail ubiquitination-degradation. The function of Col XVII was mainly dependent on shedding by ADAM9 and ADAM10. Patients who underwent surgical resection for lung cancer, and displayed overexpression of both Col XVII and laminin-5, had the worst prognosis of all expression types. Moreover, blockage of the Col XVII/laminin-5 pathway reduced the EMT phenotypes of lung CSCs in vitro and decreased the potential of lung metastasis in vivo. Our findings suggested that targeting Col XVII and laminin-5 could be novel therapeutic strategies for treating lung cancer patients, and warrant further investigation. |
format | Online Article Text |
id | pubmed-5788589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57885892018-02-07 Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer Liu, Chen-Chi Lin, Jiun-Han Hsu, Tien-Wei Hsu, Jyuan-Wei Chang, Jer-Wei Su, Kelly Hsu, Han-Shui Hung, Shih-Chieh Oncotarget Research Paper Epithelial-to-mesenchymal transition (EMT) is associated with tumor metastasis and tumorigenesis in lung cancer stem-like cells (CSCs). However, the exact mechanism underlying this is not clear. We used microarray analysis to identify candidate genes responsible for EMT in spheroid and monolayer cultures of lung cancer cells. We found increased expression of a variety of adhesion molecules in CSCs. One of these molecules, Collagen XVII (Col XVII), was demonstrated to be required for maintenance of EMT phenotypes and metastasis ability in lung CSCs. We showed that Col XVII stabilized laminin-5 to activate the FAK/AKT/GSK3β pathway, thereby suppressing Snail ubiquitination-degradation. The function of Col XVII was mainly dependent on shedding by ADAM9 and ADAM10. Patients who underwent surgical resection for lung cancer, and displayed overexpression of both Col XVII and laminin-5, had the worst prognosis of all expression types. Moreover, blockage of the Col XVII/laminin-5 pathway reduced the EMT phenotypes of lung CSCs in vitro and decreased the potential of lung metastasis in vivo. Our findings suggested that targeting Col XVII and laminin-5 could be novel therapeutic strategies for treating lung cancer patients, and warrant further investigation. Impact Journals LLC 2016-08-11 /pmc/articles/PMC5788589/ /pubmed/29416721 http://dx.doi.org/10.18632/oncotarget.11208 Text en Copyright: © 2018 Liu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Liu, Chen-Chi Lin, Jiun-Han Hsu, Tien-Wei Hsu, Jyuan-Wei Chang, Jer-Wei Su, Kelly Hsu, Han-Shui Hung, Shih-Chieh Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title | Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title_full | Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title_fullStr | Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title_full_unstemmed | Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title_short | Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
title_sort | collagen xvii/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788589/ https://www.ncbi.nlm.nih.gov/pubmed/29416721 http://dx.doi.org/10.18632/oncotarget.11208 |
work_keys_str_mv | AT liuchenchi collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT linjiunhan collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT hsutienwei collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT hsujyuanwei collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT changjerwei collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT sukelly collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT hsuhanshui collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer AT hungshihchieh collagenxviilaminin5activatesepithelialtomesenchymaltransitionandisassociatedwithpoorprognosisinlungcancer |